This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
5nx2
From Proteopedia
(Difference between revisions)
m (Protected "5nx2" [edit=sysop:move=sysop]) |
|||
| Line 1: | Line 1: | ||
| - | '''Unreleased structure''' | ||
| - | + | ==Crystal structure of thermostabilised full-length GLP-1R in complex with a truncated peptide agonist at 3.7 A resolution== | |
| + | <StructureSection load='5nx2' size='340' side='right' caption='[[5nx2]], [[Resolution|resolution]] 3.70Å' scene=''> | ||
| + | == Structural highlights == | ||
| + | <table><tr><td colspan='2'>[[5nx2]] is a 2 chain structure with sequence from [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5NX2 OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5NX2 FirstGlance]. <br> | ||
| + | </td></tr><tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat"><scene name='pdbligand=NAG:N-ACETYL-D-GLUCOSAMINE'>NAG</scene>, <scene name='pdbligand=SOG:2-HYDROXYMETHYL-6-OCTYLSULFANYL-TETRAHYDRO-PYRAN-3,4,5-TRIOL'>SOG</scene></td></tr> | ||
| + | <tr id='NonStdRes'><td class="sblockLbl"><b>[[Non-Standard_Residue|NonStd Res:]]</b></td><td class="sblockDat"><scene name='pdbligand=9DK:'>9DK</scene>, <scene name='pdbligand=9DQ:'>9DQ</scene>, <scene name='pdbligand=9DT:'>9DT</scene>, <scene name='pdbligand=9DW:'>9DW</scene>, <scene name='pdbligand=9DZ:'>9DZ</scene></td></tr> | ||
| + | <tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">GLP1R ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | ||
| + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5nx2 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5nx2 OCA], [http://pdbe.org/5nx2 PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5nx2 RCSB], [http://www.ebi.ac.uk/pdbsum/5nx2 PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5nx2 ProSAT]</span></td></tr> | ||
| + | </table> | ||
| + | == Function == | ||
| + | [[http://www.uniprot.org/uniprot/GLP1R_HUMAN GLP1R_HUMAN]] This is a receptor for glucagon-like peptide 1. The activity of this receptor is mediated by G proteins which activate adenylyl cyclase. | ||
| + | <div style="background-color:#fffaf0;"> | ||
| + | == Publication Abstract from PubMed == | ||
| + | Glucagon-like peptide 1 (GLP-1) regulates glucose homeostasis through the control of insulin release from the pancreas. GLP-1 peptide agonists are efficacious drugs for the treatment of diabetes. To gain insight into the molecular mechanism of action of GLP-1 peptides, here we report the crystal structure of the full-length GLP-1 receptor bound to a truncated peptide agonist. The peptide agonist retains an alpha-helical conformation as it sits deep within the receptor-binding pocket. The arrangement of the transmembrane helices reveals hallmarks of an active conformation similar to that observed in class A receptors. Guided by this structural information, we design peptide agonists with potent in vivo activity in a mouse model of diabetes. | ||
| - | + | Crystal structure of the GLP-1 receptor bound to a peptide agonist.,Jazayeri A, Rappas M, Brown AJH, Kean J, Errey JC, Robertson NJ, Fiez-Vandal C, Andrews SP, Congreve M, Bortolato A, Mason JS, Baig AH, Teobald I, Dore AS, Weir M, Cooke RM, Marshall FH Nature. 2017 Jun 8;546(7657):254-258. doi: 10.1038/nature22800. Epub 2017 May 31. PMID:28562585<ref>PMID:28562585</ref> | |
| - | + | From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.<br> | |
| - | + | </div> | |
| - | + | <div class="pdbe-citations 5nx2" style="background-color:#fffaf0;"></div> | |
| - | + | == References == | |
| - | + | <references/> | |
| - | + | __TOC__ | |
| - | [[Category: | + | </StructureSection> |
| - | [[Category: | + | [[Category: Human]] |
| - | [[Category: | + | [[Category: Andrews, S P]] |
| - | + | [[Category: Baig, A H]] | |
[[Category: Bortolato, A]] | [[Category: Bortolato, A]] | ||
| + | [[Category: Brown, A J.H]] | ||
| + | [[Category: Congreve, M]] | ||
| + | [[Category: Cooke, R M]] | ||
| + | [[Category: Dore, A S]] | ||
| + | [[Category: Errey, J C]] | ||
[[Category: Fiez-Vandal, C]] | [[Category: Fiez-Vandal, C]] | ||
| + | [[Category: Jazayeri, A]] | ||
[[Category: Kean, J]] | [[Category: Kean, J]] | ||
| - | [[Category: Marshall, F | + | [[Category: Marshall, F H]] |
| - | [[Category: | + | [[Category: Mason, J S]] |
| - | + | ||
| - | + | ||
[[Category: Rappas, M]] | [[Category: Rappas, M]] | ||
| - | [[Category: | + | [[Category: Robertson, N]] |
| + | [[Category: Teobald, I]] | ||
| + | [[Category: Weir, M]] | ||
| + | [[Category: Gpcr]] | ||
| + | [[Category: Membrane protein]] | ||
| + | [[Category: Signalling protein]] | ||
Revision as of 09:56, 16 November 2017
Crystal structure of thermostabilised full-length GLP-1R in complex with a truncated peptide agonist at 3.7 A resolution
| |||||||||||
Categories: Human | Andrews, S P | Baig, A H | Bortolato, A | Brown, A J.H | Congreve, M | Cooke, R M | Dore, A S | Errey, J C | Fiez-Vandal, C | Jazayeri, A | Kean, J | Marshall, F H | Mason, J S | Rappas, M | Robertson, N | Teobald, I | Weir, M | Gpcr | Membrane protein | Signalling protein
